Elevance Health (ELV) Stock Overview
Operates as a health benefits company in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for ELV from our risk checks.
ELV Community Fair Values
Create NarrativeSee what 182 others think this stock is worth. Follow their fair value or set your own to get alerts.
Elevance Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$335.87 |
| 52 Week High | US$458.75 |
| 52 Week Low | US$273.71 |
| Beta | 0.50 |
| 1 Month Change | -9.48% |
| 3 Month Change | -0.12% |
| 1 Year Change | -12.82% |
| 3 Year Change | -29.48% |
| 5 Year Change | 7.83% |
| Change since IPO | 1,542.40% |
Recent News & Updates
Recent updates
Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain
Jan 28Positive Sentiment Still Eludes Elevance Health, Inc. (NYSE:ELV) Following 25% Share Price Slump
Jul 29
Not Many Are Piling Into Elevance Health, Inc. (NYSE:ELV) Just Yet
May 31Elevance Health (NYSE:ELV) Has A Pretty Healthy Balance Sheet
May 11Elevance Health: Carelon Growth Not Fully Appreciated
Apr 23Elevance Health (NYSE:ELV) Has More To Do To Multiply In Value Going Forward
Apr 15Elevance Health: A Hidden Gem Amongst Healthcare Turbulence
Apr 15Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio
Mar 13Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now
Feb 27Elevance Health: Trading At Depressed Levels, So We Added Modestly
Jan 30Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
Jan 23ELV Market Outlook
This industry includes companies primarily engaged in providing health insurance products, managed care plans, and related healthcare services. These companies play a critical role in financing and maElevance Health Is An Undervalued Healthcare Juggernaut
Dec 26Elevance Health: A Quality Underpriced Stock Returning To Health
Dec 11Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds
Oct 17Elevance: Our Top Value Pick Trading At 12.5x Earnings And Growing At 12.5%
Oct 10Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth
Sep 06Shareholder Returns
| ELV | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -3.2% | -1.6% | -0.3% |
| 1Y | -12.8% | -15.1% | 13.9% |
Return vs Industry: ELV exceeded the US Healthcare industry which returned -15.1% over the past year.
Return vs Market: ELV underperformed the US Market which returned 13.9% over the past year.
Price Volatility
| ELV volatility | |
|---|---|
| ELV Average Weekly Movement | 5.8% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ELV has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ELV's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 96,615 | Gail Boudreaux | www.elevancehealth.com |
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits.
Elevance Health, Inc. Fundamentals Summary
| ELV fundamental statistics | |
|---|---|
| Market cap | US$75.69b |
| Earnings (TTM) | US$5.66b |
| Revenue (TTM) | US$199.13b |
Is ELV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ELV income statement (TTM) | |
|---|---|
| Revenue | US$199.13b |
| Cost of Revenue | US$148.22b |
| Gross Profit | US$50.90b |
| Other Expenses | US$45.24b |
| Earnings | US$5.66b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 25.65 |
| Gross Margin | 25.56% |
| Net Profit Margin | 2.84% |
| Debt/Equity Ratio | 72.9% |
How did ELV perform over the long term?
See historical performance and comparisonDividends
Does ELV pay a reliable dividends?
See ELV dividend history and benchmarks| Elevance Health dividend dates | |
|---|---|
| Ex Dividend Date | Mar 10 2026 |
| Dividend Pay Date | Mar 25 2026 |
| Days until Ex dividend | 13 days |
| Days until Dividend pay date | 28 days |
Does ELV pay a reliable dividends?
See ELV dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/23 17:24 |
| End of Day Share Price | 2026/02/23 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Elevance Health, Inc. is covered by 39 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Hua Ha | Baird |
| Joshua Raskin | Barclays |